Literature DB >> 9473074

Positron emission tomography in the evaluation of the N0 neck.

L L Myers1, M K Wax, H Nabi, G T Simpson, D Lamonica.   

Abstract

The presence of cervical lymph node metastasis in patients with head and neck cancer is associated with an unfavorable prognosis. Reports vary as to whether various conventional radiographic studies, such as computed tomography (CT) and magnetic resonance imaging, confer an advantage over physical examination in the patient without clinical findings of cervical metastasis (N0). Positron emission tomography (PET) is a functional imaging modality that has recently been used for head and neck neoplasms. The use of PET in the evaluation of the N0-staged neck in 14 consecutive patients with squamous cell carcinoma (SCC) of the upper aerodigestive tract is reported. Seven patients (50%) undergoing 13 neck dissections had pathologic evidence of disease. PET scans were positive in five patients with pathologically confirmed cervical metastasis. PET scans were negative in seven patients (11 neck dissections) with no pathologic evidence of disease. PET scans were positive for unilateral cervical metastasis in two of three patients with involvement of a single lymph node. PET scans were positive in two of three patients with more than two lymph nodes involved. PET had an accuracy of 100% in the eight patients with SCC of the oral cavity. In patients with oropharyngeal or hypopharyngeal carcinoma PET localized cervical metastasis in two of four patients with neck metastasis. In the patient with an N0-staged neck on clinical examination, PET was found to have an overall sensitivity of 78%, specificity of 100%, positive predictive value of 100%, negative predictive value of 88%, and accuracy of 92%. CT demonstrated sensitivity of 57%, specificity of 90%, positive predictive value of 80%, negative predictive value of 75%, and accuracy of 76%. PET showed a trend in increased accuracy (P = 0.11) over CT. PET appears to be a promising diagnostic aid that may be applied when evaluating the N0-staged neck, especially for SCC of the oral cavity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473074     DOI: 10.1097/00005537-199802000-00014

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

1.  Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.

Authors:  Val J Lowe; Fenghai Duan; Rathan M Subramaniam; JoRean D Sicks; Justin Romanoff; Twyla Bartel; Jian Q Michael Yu; Brian Nussenbaum; Jeremy Richmon; Charles D Arnold; David Cognetti; Brendan C Stack
Journal:  J Clin Oncol       Date:  2019-02-15       Impact factor: 44.544

2.  Comparison of PET/CT with conventional imaging modalities (USG, CECT) in evaluation of N0 neck in head and neck squamous cell carcinoma.

Authors:  Ashutosh Chauhan; Pranjal Kulshrestha; Sanjay Kapoor; Harkirat Singh; M J Jacob; Maneel Patel; Manomoy Ganguly
Journal:  Med J Armed Forces India       Date:  2012-07-17

3.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.

Authors:  M P Stokkel; F W ten Broek; G J Hordijk; R Koole; P P van Rijk
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

4.  Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?

Authors:  Jolijn Brouwer; Remco de Bree; Emile F I Comans; Jonas A Castelijns; Otto S Hoekstra; C René Leemans
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

5.  Multimodal in vivo imaging of oral cancer using fluorescence lifetime, photoacoustic and ultrasound techniques.

Authors:  Hussain Fatakdawala; Shannon Poti; Feifei Zhou; Yang Sun; Julien Bec; Jing Liu; Diego R Yankelevich; Steven P Tinling; Regina F Gandour-Edwards; D Gregory Farwell; Laura Marcu
Journal:  Biomed Opt Express       Date:  2013-08-26       Impact factor: 3.732

6.  Impact of combined (18)F-FDG PET/CT in head and neck tumours.

Authors:  R Syed; J B Bomanji; N Nagabhushan; S Hughes; I Kayani; A Groves; S Gacinovic; N Hydes; D Visvikis; C Copland; P J Ell
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

7.  A Pilot Study: N-Staging Assessment of Shear Wave Elastrography in Small Cervical Lymph Nodes for Nasopharyngeal Carcinoma.

Authors:  Ying Guan; Shuai Liu; An-Chuan Li; Xin-Bin Pan; Zhong-Guo Liang; Wan-Qin Cheng; Xiao-Dong Zhu
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

8.  Significance of PET-CT for Detecting Occult Lymph Node Metastasis and Affecting Prognosis in Early-Stage Tongue Squamous Cell Carcinoma.

Authors:  Guo Zhao; Jianli Sun; Kai Ba; Yunxiang Zhang
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

9.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

Review 10.  The role of ultrasound in the detection of cervical lymph node metastases in clinically N0 squamous cell carcinoma of the head and neck.

Authors:  P S Richards; T E Peacock
Journal:  Cancer Imaging       Date:  2007-11-19       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.